cyclosporine and Cockayne-Touraine Disease

cyclosporine has been researched along with Cockayne-Touraine Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
De, D; Handa, S; Karim, A; Kaushik, A; Mahajan, R; Saikia, B1
Boull, CL; Hook, KP; Hylwa, SA; Sajic, D; Tolar, J; Wagner, JE1
Ito, M; Mizutani, Y; Nakano, H; Sawamura, D; Seishima, M; Takahashi, T1
Abdel Halim, DM; Abdel Hay, RM; Amin, IM; El-Darouti, MA; Fawzy, MM; Hegazy, RA1
Anadolu, R; Calikoglu, E1
del-Río, E1
Arata, J; Tada, J; Yamasaki, H; Yoshioka, T1

Trials

1 trial(s) available for cyclosporine and Cockayne-Touraine Disease

ArticleYear
Mycophenolate mofetil: a novel immunosuppressant in the treatment of dystrophic epidermolysis bullosa, a randomized controlled trial.
    The Journal of dermatological treatment, 2013, Volume: 24, Issue:6

    Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Epidermolysis Bullosa Dystrophica; Female; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Male; Mycophenolic Acid; Survival Rate; Treatment Outcome; Young Adult

2013

Other Studies

6 other study(ies) available for cyclosporine and Cockayne-Touraine Disease

ArticleYear
Successful use of cyclosporine in epidermolysis bullosa pruriginosa.
    Dermatologic therapy, 2020, Volume: 33, Issue:6

    Topics: Adult; Collagen Type VII; Cyclosporine; Epidermolysis Bullosa; Epidermolysis Bullosa Dystrophica; Humans; Male

2020
Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.
    The Journal of pediatrics, 2016, Volume: 173

    Topics: Bone Marrow Transplantation; Child, Preschool; Cyclosporine; Epidermolysis Bullosa Dystrophica; Humans; Immunosuppressive Agents; Male; Mesenchymal Stem Cell Transplantation; Stevens-Johnson Syndrome

2016
Dystrophic epidermolysis bullosa pruriginosa successfully treated with immunosuppressants.
    The Journal of dermatology, 2016, Volume: 43, Issue:11

    Topics: Adult; Aged; Cyclosporine; Epidermolysis Bullosa Dystrophica; Female; Humans; Immunosuppressive Agents; Ribonucleosides

2016
Management of generalized pruritus in dominant dystrophic epidermolysis bullosa using low-dose oral cyclosporin.
    Acta dermato-venereologica, 2002, Volume: 82, Issue:5

    Topics: Administration, Oral; Adult; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Epidermolysis Bullosa Dystrophica; Female; Follow-Up Studies; Humans; Pruritus; Risk Assessment; Severity of Illness Index; Treatment Outcome

2002
Prevention of blisters in dystrophic recessive epidermolysis bullosa with cyclosporine.
    Journal of the American Academy of Dermatology, 1993, Volume: 29, Issue:6

    Topics: Adult; Blister; Cyclosporine; Epidermolysis Bullosa Dystrophica; Female; Humans

1993
Epidermolysis bullosa pruriginosa (McGrath) successfully controlled by oral cyclosporin.
    The British journal of dermatology, 1997, Volume: 137, Issue:2

    Topics: Cyclosporine; Epidermolysis Bullosa Dystrophica; Humans; Immunosuppressive Agents; Leg Dermatoses; Male; Middle Aged; Prurigo

1997